Background Private sector partnerships through community pharmacies are essential for
effective healthcare integration to achieve the United Nations 2030 Agenda for Sustainable …

Background As a computerized drug–drug interaction (DDI) alert system has not been
widely implemented in China, health care providers are relying on mobile health (mHealth) …

Background Drug-drug interactions (DDIs) can cause treatment failure and serious adverse
drug reactions, leading to morbidity and mortality. Due to their significant effects on the …

Purpose. The growing choice of oral anticancer medications (OAMs) delivered in
pharmacies puts the patients at the center of their own therapeutic management. Patient …

Background: Drug interactions are the most common preventable cause of adverse drug
reaction, which may result in drug toxicity or undesired therapeutic effect with harmful …

Introduction Patients frequently use gastric acid-reducing agents (ARAs) to treat symptoms
affecting the gastrointestinal tract. Thus, the risk for drug–drug interactions (DDI) is a serious …

Abstract Introduction: In December 2019, dolutegravir-based treatment was recommended
as first-line antiretroviral therapy (ART) in South Africa. Dolutegravir has clinically significant …

Asthma is a chronic respiratory disease that results in a constriction of the airway. The study
aimed to evaluate the potential drug-drug interactions (PDIs) among asthma patients. A …

Background Pharmacists have an important role in preventing prescribing errors and
providing appropriate information. They can detect potential drug–drug interactions (DDIs) …

Abstract Objectives Drug–food interactions (DFIs) are a problem in clinical practice as they
can alter the bioavailability of drugs and nutrients and may lead to various adverse effects …